García RY, Rosabal RZ, Zozaya AB, Castilla SA, Rodríguez GMI, Medina RI

Language: Spanish
References: 28
Page: 180-188
PDF size: 145.97 Kb.

ABSTRACT

The endogenous endophthalmitis may occur in cases of internal tissue inflammation secondary to intraocular infection, as a result of the hematogenous dissemination of microorganisms from a distal focus to the eye. It is the less frequent group of all types of endophthalmitis (5 %), preferably unilateral, and most of the cases present with an extraocular infectious focus. Although it may appear in healthy immuno competent patients, this endophthalmitis mainly affects patients with one or more risk factors such as chronic illnesses, surgical procedures, neoplasias, parenterally administered drug users, immunodeficiencies and intravenous catheters. A case of a diabetic female patient with endogenous endophthalmitis secondary to a renal tumo was presented. Her initial clinical picture pointed to diabetic coma, but as the disease evolved and based on the ophthalmological study, it was possible to reach a complete diagnosis and to apply a treatment for her health problem.

REFERENCES

1. Ciprés MC, Folch J, Romero Rubiols B. Generalidades de las endoftalmitis. Annals d'Oftalmologia. 2008;16(5):264-74.

2. Yang CS, Tsai HY, Sung CS, Lin KH, Lee FL, Hsu WM. Endogenous Klebsiella endophthalmitis associated with pyogenic liver abscess. Ophthalmology. 2007;114(5):876-80.

3. Essman TF, Flynn HW Jr, Smiddy WE, Brod RD, Murray TG, Davis JL, et al. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers. 1997;28(3):185-94.

4. Binder MI, Chua J, Kaiser PK, Procop GW, Isada CM. Endogenous endophthalmitis: a 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore). 2003;82(2):97-105.

5. Jackson TL, Eykyn SJ, Graham EM, Stanford MR. Endogenous bacterial endophthalmitis: a 17 year prospective series and review of 267 reported cases. Surv Ophthalmol. 2003;48(4):403-23.

6. Leibovitch I, Lai T, Raymond G, Zadeh R, Nathan F, Selva D. Endogenous endophthalmitis: a 13 year review at a tertiary hospital in South Australia. Scand J Infect Dis. 2005;37(3):184-9.

7. Ness T, Pelz K, Hansen LL. Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmol Scand. 2007;85(8):852-6.

8. Wong JS, Chan TK, Lee HM, Chee SP. Endogenous bacterial endophthalmitis: An East Asian experience and reappraisal of a severe ocular affliction. Ophthalmology. 2000;107(8):1483-91.

9. Okada AA, Johnson RP, Liles WC, D'Amico DJ, Baker AS. Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology. 1994;101(5):832-8.

10. Rahav G, Levinger S, Fruncht-Pery J. Escherichia coli endophthalmitis secondary to pyelonephritis: another complication of diabetes?. Clin Infect Dis. 1994;18(1):117-8.

11. Reedy JS, Wood KE. Endogenous pseudomonas aeruginosa endophthalmitis: a case report and literature review. Intens Care Med. 2000;26:1386-9.

12. Rao NA, Hidayat AA. A comparative clinicopathologic study of endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared to aspergillosis. Trans Am Ophthalmol Soc. 2000;98:183-93.

13. Schiedler V, Scott IU, Flynn HW Jr, Davis JL, Bens MS, Miller D. Cultureproven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol. 2004;137(4):725-31.

14. Gerkowicz M, Pietras-Trzpiel M, Koziol-Montewka M, Kosior-Jarecka E, Latalska M, Paluch-Olés J. Application of polymerase chain reaction method (PCR) in diagnosis of endophthalmitis. Klin Oczna. 2006;108(7-9):319-22.

15. Ness T, Serr A. Diagnostic for endophthalmitis. Klin Monatsbi Augenheilkd. 2008;225(1):44-9.

16. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of inmediate vitrectomy and intravenous antibiotics for the treatment of posoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113(12):1479-96.

17. Khan A, Okhravi N, Lightman S. The eye in systemic sepsis. Cliniclal Medicine. J Royal College Physicians. 2002;2(5):444-8.

18. Takebayashi H, Mizota A, Tanaka M. Relation between stage of endogenous fungal endophthalmitis and prognosis. Graefes Arch Clin Exp Ophthalmol. 2006;244(7):816-20.

19. Chen SC, Sorrell TC. Antifungal agents. Med J Aust. 2007;187(7):404-9.

20. Horcajada JP, Fernández-Sampedro M, García-Palomo D, Cañal J, Salesa R, Farinas MC. Endogenous ocular candidiasis: changes in epidemiology and factors associated with poor functional outcome. Scand J Infect Dis. 2007;39(3):225-30.

21. Benz MS, Scott IU, Flynn HW Jr, Unonius N, Miller D. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol. 2004;137(1): 38-42.

22. Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol. 2005;139(1):135-40.

23. Khan FA, Slain D, Khakoo RA. Candida endophthalmitis: focus on current and future antifungal treatment options. Pharmacotherapy. 2007;27(12):1711-21.

24. Osthoff M, Hilge R, Schulze-Döbold C, Bogner JR. Endogenous endophthalmitis with azole- resistant Candida albicansCase report and review of the literature. Infection. 2006;34(5):285-8.

25. Hariprasad SM, Mieler WF, Holz ER, Gao H, Kim JE, Chi J, et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazol in humans. Arch Ophthalmol. 2004;122(1):42-7.

26. Mensa J, Gatell JM, Azanza JR. Guía de terapéutica antimicrobiana. 17ma ed. Barcelona: Elsevier Masson; 2007.

27. Greenwald MJ, Wohl LG, Sell CH. Metastatic bacterial endophthalmitis: a contemporary reappraisal. Surv Ophthalmol. 1986;31(2):81-101.

28. Bouza E, Cobo-Soriano R, Rodriguez-Creixems M, Muñoz P, Suárez-Leoz M, Cortés C. A prospective search for ocular lesions in hospitalized patients with significant bacteremia. Clin Infect Dis. 2000;30(2):306-312.